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ABSTRACT
BLM and WRN are members of the RecQ family
of DNA helicases, and in humans their loss is
associated with syndromes characterized by
genome instability and cancer predisposition.
As the only RecQ DNA helicase in the yeast
Saccharomyces cerevisiae, Sgs1 is known to safe-
guard genome integrity through its role in DNA
recombination. Interestingly, WRN, BLM and Sgs1
are all known to be modified by the small
ubiquitin-related modifier (SUMO), although the sig-
nificance of this posttranslational modification
remains elusive. Here, we demonstrate that Sgs1
is specifically sumoylated under the stress of DNA
double strand breaks. The major SUMO attachment
site in Sgs1 is lysine 621, which lies between the
Top3 binding domain and the DNA helicase
domain. Surprisingly, sumoylation of K621 was
found to be uniquely required for Sgs1’s role in
telomere–telomere recombination. In contrast,
sumoylation was dispensable for Sgs1’s roles in
DNA damage tolerance, supppression of direct
repeat and rDNA recombination, and promotion of
top3D slow growth. Our results demonstrate that
although modification by SUMO is a conserved
feature of RecQ family DNA helicases, the major
sites of modification are located on different
domains of the protein in different organisms. We
suggest that sumoylation of different domains of
RecQ DNA helicases from different organisms
contributes to conserved roles in regulating
telomeric recombination.
INTRODUCTION
Chromosomal DSBs, caused by replication fork disrup-
tion, environmental factors or endogenous nucleases are
common yet potentially dangerous DNA lesions in all
organisms. DNA DSBs are critical lesions that if
unrepaired or misrepaired may be lethal for a cell or con-
tribute to its malignant transformation. DSBs can be
repaired either by homologous recombination or by
non-homologous end joining pathways (1–6). In this
regard, the budding yeast Saccharomyces cerevisiae has
become the most intensely studied model system for
DSB DNA repair.
RecQ proteins comprise a highly conserved family of 30–
50 DNA helicases that includes the human BLM, WRN,
RECQL4 and RECQ5 proteins, as well as Rqh1 from
Schizosaccharomyces pombe and Sgs1 in S. cerevisiae (7–
9). Werner’s, Bloom’s and Rothmund-Thomson’s genome
instability syndromes are caused by mutation of the WRN,
BLM and RECQL4 genes, respectively (10–12). RecQ
DNA helicases have been implicated in several aspects
of DNA metabolism (8), including a recently
characterized role in the initial step of homologous recom-
bination in S. cerevisiae (13,14). After a DSB is formed
and recognized, Sae2 trims the ends to create a minimally
resected intermediate. Sgs1 and Exo1 then rapidly process
this intermediate to generate extensive tracts of single-
strand DNA that serve as substrates for Rad51 in homol-
ogous recombination (13,14).
Posttranslational modiﬁcation with the small ubiquitin-
related modiﬁer (SUMO), is a widespread mechanism
for rapid and reversible changes in protein function.
Sumoylation occurs by a process that is similar to
ubiquitylation. An E1 activating protein (Aos1/Uba2)
loads SUMO onto the E2 conjugating enzyme (Ubc9),
which in turn transfers SUMO (Smt3 in budding yeast)
onto speciﬁc lysine residues within target substrates (15).
Sumoylation has recently been reported to regulate Rqh1
activity at telomeres in S. pombe (16). Moreover, WRN,
BLM and Sgs1 were all previously shown to be sumoylated
(17–19), although the exact role of this modiﬁcation in
homologous recombination is not completely understood.
In the absence of telomerase, immortalized mammalian
cells and yeast may employ recombination-mediated
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lengthening of telomeres (ALT), in mammalian cells
(20–22). Telomerase-negative S. cerevisiae overcomes
telomere crisis by utilizing one of two Rad52-dependent
recombination-mediated pathways, termed Types I and II
(23,24). Type I telomere lengthening requires Rad51,
whereas Type II telomere lengthening requires Rad50
and the Sgs1/Top3 complex (25–29). Telomeric repeats
in Type II survivors are ampliﬁed and often heterogeneous
in length, whereas Type I survivors have ampliﬁed
subtelomeric Y0-elements. Terminal telomeric repeats in
human cells using ALT are long and heterogeneous, sug-
gesting that a Type II-like mechanism is used in these
pathways (20–22).
The association of Sgs1 with the Type II recombination
pathway prompted us to hypothesize a conserved function
of these RecQ helicases in recombination-mediated
telomere lengthening. Furthermore, very recently, Rqh1
has been reported to control the fate of dysfunctional
telomeres (16). In this study, we demonstrate that DSBs
induced by ionizing radiation (IR) or chemicals, but not
replication fork disruption or oxidative stress, promote
Sgs1 sumoylation. The major SUMO attachment site in
Sgs1 is lysine 621, which lies between the Top3 binding
and DNA helicase domains (30,31). A conservative
mutation at this residue reduces Type II telomere–
telomere recombination, but does not alter the functions
of Sgs1 in DSB repair and homologous recombination
at other loci in the genome. This indicates that
sumoylation of Sgs1 speciﬁcally facilitates telomere–
telomere recombination.
MATERIALS AND METHODS
Yeast strains and plasmids
All the yeast operations were performed by standard
methods (32). STY1525 (YPH499 SGS1-13Myc) was con-
structed by double crossing over the chromosomal SGS1
gene of YPH499 (24) with a 13Myc PCR fragment from
pFA6a-13Myc-kanMX6 (33). STY1793 (YPH499 ubc9-1
SGS1-13Myc) was obtained by three backcrosses of
MR966 ubc9-1 (34) with YPH499, ULP1 and ULP2
plasmids, which were kindly provided by Dr Mark
Hochstrasser (35,36). pRS306-SGS1 was constructed
as described below. Point mutations were introduced
into pRS306-SGS1 using QuikChange site-directed
mutagenesis (Stratagene). To generate chromosomal sgs1
mutants, pRS306-sgs1 mutants were linearized by AﬂII
and transformed into SGS1 strains, and URA3 pop-out
mutants were identiﬁed from 5-FOA-resistant colonies
using PCR analysis. Both E3 deletion mutants were
purchased from yeast deletion library (Invitrogen). The
sgs1::HIS3 mutation was constructed by transforming
these strains with an sgs1::HIS3 PCR fragment ampliﬁed
from STY680 (sgs1::HIS3) (27) genomic DNA using an
SGS1 upstream and downstream primer pairs. YPH499
exo1 strains were generated by transplacement of the
YPH499 EXO1 locus with an exo1::kanMX6 fragment
ampliﬁed from yeast deletion library (Invitrogen).
STY1881 (YPH500 top3::URA3) was generated using a
URA3 fragment that was PCR-ampliﬁed from pMPY-
3xHA (37) using oligonucleotides with sequences homol-
ogous to the TOP3 upstream and downstream regions.
This knockout fragment was then introduced into the
indicated strains. For the inter-chromosomal recombina-
tion assay, MR966 and MR93-28c (34) were manipulated
independently and mated to obtain diploid cells. The
sgs1::URA3 mutation was generated by transforming
strains with an sgs1::URA3 PCR fragment ampliﬁed
using primers with sequences homologous to the SGS1
up- and downstream regions. pRS316-SGS1 was a
backbone exchange construct of pRS314-SGS1 (27). A
SacII-SacI fragment containing the C-terminal SGS1
and 13Myc regions was cloned into the SacII/SacI-
digested pRS316-SGS1 to generate pRS316-SGS1-
13Myc. pRS306-SGS1 for two-step gene replacement
was cloned by ligation of an XhoI/BamHI fragment
from pRS316-SGS1-13Myc into pRS306. pGEX-4T-
SGS1 (410–713) was constructed by ligating the BamHI/
PstI-Klenow-treated fragment containing the aa 410–713
of Sgs1 into the BamHI/SmaI-digested pGEX4T-1 (GE).
All primer sequences for PCR and mutagenesis are avail-
able upon request.
Western blotting analysis and in vitro sumoylation assay
Early log phase cultures were grown to an OD600 of 0.5
and extracts were prepared for western blotting using an
anti-Myc antibody. The signal was quantitated using
ImageQuant software Version 5.2 (GE). The His6-tagged
yeast SUMO E1, E2 and Smt3 expression plasmids were
kindly provided by Drs Gu ¨ nter Blobel (38) and Ting-Fang
Wang (39). Puriﬁcation of these enzymes was performed
as described (38). Recombinant GST-Sgs1 was expressed
in the BL21 strain and puriﬁed according to the manufac-
turer (GE). For the in vitro sumoylation assay, 1mgo f
SUMO, 2mg of Aos1/Uba2, 2.5mg of Ubc9 and 5mgo f
substrate were incubated at 30 C for 2h. Reactions were
performed in 50ml reaction buﬀer containing 50mM
HEPES (pH 7.5), 100mM NaCl, 10mM MgCl2,2 0 mg
bovine serum albumin, 5mM Tris, 0.1mM DTT and
5mM ATP.
Spot dilution assay
For the spot dilution assay, early log phase cultures were
adjusted to an OD600 of 0.5 and serial 5-fold dilutions
were made in sterial water. Five microliters were spotted
onto YPD plates, followed by exposure to diﬀerent
temperatures, ionizing radiation (IR), or UV light.
Alternatively, cells were spotted onto YPD plates contain-
ing various concentrations of methyl methanesulphonate
(MMS), ethyl methanesulfonate (EMS), bleomycin
or hydroxyurea (HU). Drug-containing plates were
prepared 2 days before use.
Yeast telomere analysis
Liquid cultures were generated by inoculating spore
colonies from the freshly dissected spores into 10ml of
liquid YEPD medium. Cultures were diluted repeatedly
1:10000 into fresh medium and grown at 30 C for
48–72h to reach the stationary phase. Solid-media
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colonies from the dissection plates onto YEPD plates.
To quantify the ratio of Type I versus Type II survivors,
spore cells were serially restreaked onto YEPD medium
as described (40) to obtain survivors on solid
media. Genomic DNA was digested with a mixture of
HaeIII, HinfI and MspI, and Southern blot analysis
was performed using a telomere probe as previously
described (40).
Competition assay for formation of survivors
The tlc1D and tlc1D sgs1-K621R cells were taken from
freshly dissected spore colonies and mixed in a 50:50
ratio in YEPD medium. Following growth to stationary
phase, cultures were diluted 1:10000 every 2 days, for 12
days. Genomic DNA was extracted from cultures at the
indicated time points and subjected to quantitative real-
time PCR to determine the genomic background of SGS1
using speciﬁc primers. The tubulin gene was used as an
internal control. The primer speciﬁc for wild-type SGS1 is
GACTAACACTGGATTTCTCCCTTT and for sgs1-
K621R is GACTAACACTGGATTTCTCCCTTC (the
underline indicates the diﬀerence in the mutant). Control
experiments showed that the primers did not cross-amplify
non-speciﬁc products (data not shown). Data were
expressed as a percentage of the sum of the signals
ampliﬁed from SGS1 and sgs1-K621R in individual
cultures. Other primer sequences for PCR are available
upon request.
Assays for recombination frequency
Recombination between direct repeats was assayed in the
indicated strains following transformation with pRS314-
Lu (41). Fresh transformants were ﬁrst patched onto
YEPD plates for 24h. Cells were then resuspended in
water and diluted onto synthetic complete (SC) plates
(with or without leucine) to score recombination fre-
quency. To determine the inter-chromosomal recombina-
tion frequency between his1-1 and his1-7 heteroalleles,
independent colonies of indicated strains were patched
on YEPD plates for 24h. Cells were then resuspended in
water and diluted onto SC plates (with or without
histidine) containing 0 or 0.01% of MMS to monitor via-
bility and recombination frequency. It is worth noting that
this assay could not distinguish between gene conversion
and recombination.
rDNA recombination
The frequency of intra-chromosomal rDNA recombina-
tion was monitored by measuring the frequency of loss
of the URA3 marker in strain STY1880 (rDNA::URA3
sgs1::HIS3). STY1880 was constructed from strain
W979-3B (rDNA::URA3) as described above (42).
Strains were then transformed with pRS314-based
plasmids carrying either wild-type or mutant SGS1
genes. Five independent transformants of each genotype
were grown to stationary phase in 2ml of non-selective
medium and then diluted appropriately and spread onto
SC plates with or without 5-FOA.
RESULTS
Lysine 621 is the major sumoylation site of Sgs1
The ﬁnding that Sgs1 was sumoylated (19) prompted us to
study its signiﬁcance on the cellular functions of Sgs1. In
order to optimize our ability to detect this modiﬁcation,
Sgs1 was chromosomally tagged with Myc13. We found
that treatment of yeast cells with 0.3% MMS for 30min
induced a slower migrating form of Sgs1 as detected by
immunoblot analysis (Figure 1A). The size of this mobility
shift is consistent with the addition of one SUMO moiety
(Smt3,  11kDa). The fact that the slower band required
wt SUMO E2 activity (UBC9) and was sensitive to
overexpression of either de-sumoylase ULP1 or ULP2
(35,36) (Figure 1B) suggests that the upper band is the
sumoylated form of Sgs1.
There are three major SUMO E3 ligases in budding
yeast (Siz1, Siz2 and Mms21) (43), and a previous study
showed that Mms21 was not required for the sumoylation
of Sgs1 (19). Deletion of SIZ1 or SIZ2 did not
signiﬁcantly reduce the level of sumoylated Sgs1 (Figure
1C). This suggests that SIZ1 and SIZ2 are redundant in
promoting the conjugation of SUMO onto Sgs1.
There are three SUMO consensus sites (WKxE) (44)
within Sgs1 (aa 175, 621 and 831, Figure 1D). To
identify the in vivo sumoylation site of Sgs1, each of
these lysines was mutated to arginine. Sgs1 sumoylation
was abolished by the K621R mutation, diminished by
K831R and unaﬀected by K175R (Figure 1E; data not
shown). This indicates that K621 is essential for
sumoylation in vivo. To conﬁrm that K621 is an authentic
site for sumoylation, a fragment of Sgs1 containing this
residue was puriﬁed from E. coli and used in an in vitro
sumoylation assay. As shown in Figure 1F, the wild-type
Sgs1 fragment was eﬃciently sumoylated, whereas protein
containing the K621R mutation was not. These data
indicate that K621 is the major sumoylation site of Sgs1.
Sumoylation of Sgs1 occurs in a lesion-dependent manner
We next examined the conditions necessary for the induc-
tion of Sgs1 sumoylation. Modiﬁcation of Sgs1 was rarely
observed in wild-type cells grown under normal
conditions, but a fraction of sumoylated protein
appeared after culturing the cells in the presence of at
least 0.3% MMS (Figure 1A). We, therefore, tested
whether sublethal concentrations of the following DNA-
damaging agents induced Sgs1 sumoylation: bleomycin
and IR (which lead to DSB formation), hydroxyurea
(which results in replication forks stalling) and H2O2
(which induces oxidative stress). In contrast to
hydroxyurea- or H2O2-treated cells, Sgs1 sumoylation
was observed because of treatment with bleomycin, IR
or EMS (Figure 2A). These results indicate that Sgs1
sumoylation is elicited speciﬁcally under conditions that
generate DSBs.
We next asked whether Sgs1 sumoylation was impor-
tant for growth in the absence of DNA damage. Relative
growth rates were determined by an assay in which two
types of cells are mixed and scored for their ability to
proliferate. Wild-type Leu
  cells were mixed at a 50:50
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+ cells of
the same mating type and allowed to grow without selec-
tion. Cultures were diluted every day, and after 7 days
they were plated onto selective and nonselective media
to measure the populations in the cultures. Data collected
in this manner showed that sgs1D cells had reduced
proliferative capacity. However, sgs1-K621R and sgs1-
K831R cells gave results that were indistinguishable from
those of the wild-type (Supplementary Figure S1). Thus,
sumoylation of Sgs1 does not provide any growth advan-
tage to yeast cells.
Because a major function of Sgs1 is to cope with the
genotoxic insults, we tested whether sumoylation of Sgs1
contributes to DNA damage tolerance. Deletion of SGS1
confers sensitivity to DNA damage, a phenotype that is
often attributed to defects in DNA repair (45). To deter-
mine if sgs1-K621R cells have similar repair defects, we
tested their sensitivity to MMS, bleomycin and
hydroxyurea by spotting serially diluted cells onto plates
containing these drugs (Figure 2B, Supplementary Figure
S2B). Alternatively, cells were treated with MMS before
plating (Supplementary Figure S2A), or exposed to
UV light immediately after plating (Supplementary
Figure S2B). While sgs1D cells were MMS, bleomycin,
hydroxyurea and UV sensitive, the sgs1-K621R and
sgs1-K831R cells grew as well as wild-type cells under
these treatments (Figure 2B; Supplementary Figure S2).
Diploid sgs1D cells display heightened sensitivity to these
agents relative to haploid strains (34). Therefore, we tested
MMS sensitivity in homozygous diploid cells. Again,
diploid mutant cells showed wt levels of DNA damage
tolerance (Figure 2B). Further, Exo1 and Sgs1 have
been found to collaborate in DNA DSB processing
(13,14). We, therefore, tested whether deletion of EXO1
would amplify the contribution of Sgs1 sumoylation in
DNA repair, by conducting similar experiments in the
exo1 background. As shown in Figure 2B, exo1 sgs1-
K621R and exo1 sgs1-K831R cells displayed the same
MMS sensitivity as exo1 cells. Altogether, these data dem-
onstrate that, unlike sgs1D cells, sgs1-K621R cells have
wild- or near-wild-type abilities to repair exogenously
generated DNA damage.
Sgs1 K621 sumoylation modulates telomere–telomere
recombination
Previous studies have shown that Sgs1 deﬁciency
eliminates telomere–telomere recombination in
telomerase-deﬁcient cells (25,27–29). We, therefore,
analyzed whether the loss of Sgs1 sumoylation similarly
inﬂuences this phenotype. Freshly generated tlc1D
(telomerase deﬁcient) sgs1 spore clones were repeatedly
grown to saturation in liquid culture for analysis
of telomeric recombination patterns by Southern blot.
As shown in Figure 3, we analyzed recombinants from
tlc1D, tlc1D sgs1D, tlc1D sgs1-K621R and tlc1D
sgs1-K831R spores. Compared with the tlc1D and tlc1D
sgs1-K831R strains, which displayed the Type II
Figure 1. The K621 residue of Sgs1 is critical for its sumoylation. (A) Sgs1 was chromosomally tagged with Myc13. Cells were grown to early log
phase and subjected to various dosages and times of MMS treatment. Lysates were extracted and western blot analysis was performed using an anti-
Myc antibody. (B) Wild-type and ubc9-1 strains overexpressing the indicated desumoylases were treated with or without 0.3% of MMS for 2h and
treated as above. (C) The sgs1D, sgs1D siz1D and sgs1D siz2D strains containing pRS316-SGS1-Myc13 were subjected to MMS treatment as described
above. (D) Schematic representation of the position of SUMO consensus motifs and domains within Sgs1. T, Top3-interacting domain; A, acidic
region; R, RecQ C-terminal homology region; H, Helicase and RNaseD C-terminal region. (E) Wild-type, sgs1-K621R and sgs1-K831R cells were
subjected to MMS treatment as described above. Sumoylated Sgs1 is marked with an asterisk. ( ) and (+) refers to treatment without or with
MMS, respectively. (F) Recombinant Aos1/Uba2 (E1), Ubc9 (E2), Smt3 and puriﬁed GST-Sgs1(410–713) were incubated at 30 C for 2h in the
absence ( ) or presence (+) of ATP as described in the ‘Materials and Methods’ section. Western blot analysis was then performed using an anti-
GST antibody.
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dilutions, such a pattern was absent in the tlc1D sgs1D
and tlc1D sgs1-K621R strains. Instead these cells
produced the signal expected for Y0–Y0 (Type I) recombi-
nation. Moreover, the appearance of this Type I signal
was signiﬁcantly delayed relative to the onset of Type II
recombinants. Thus, Sgs1 K621 sumoylation is function-
ally important for telomere–telomere recombination.
Sgs1 K621 sumoylation promotes the generation of
Type II survivors
Since Sgs1 sumoylation is functionally important for
telomeric recombination, we tested whether the modiﬁca-
tion stimulates Type II telomere–telomere recombination
or whether it represses Type I Y0–Y0 ampliﬁcation. Either
mechanism would lead to the observed reduction in Type
II recombinants in tlc1D sgs1-K621R cells (Figure 3). To
distinguish between these two possibilities, a competition
assay for survivor formation was performed. Cells from
tlc1D and tlc1D sgs1-K621R spore colonies were mixed at
a 50:50 ratio, and repeatedly diluted and grown to satu-
ration. Quantitative PCR was used to show that, over
time, the proliferation of the sgs1-K621R strain
was compromised relative to the tlc1D single mutant
(Figure 4A). The reduced survival of this strain indicates
that telomeric healing is diminished and suggests that
sumoylation promotes Type II events.
Consistent with this interpretation, we performed senes-
cence assays on solid media and isolated one hundred
tlc1D sgs1-K621R survivors. DNA was then prepared
from individual survivors and the telomere pattern was
determined by Southern blot analysis. Signiﬁcantly, all
of the sgs1-K621R survivors (100 of 100) displayed the
Type I pattern (data not shown). In contrast, tlc1D
single mutants generate both Types I and II survivors
(40). Taken together, these data indicate that Sgs1 K621
sumoylation stimulates Type II recombination.
To conﬁrm this idea, we relied on the fact that Rad51 is
required for Type I Y0–Y0 ampliﬁcation and that tlc1D
rad51D strains generate exclusively Type II survivors
(24,26). If Sgs1 sumoylation is important for Type II
telomere–telomere recombination, then sgs1-K621R
should have an inhibitory eﬀect on tlc1D rad51D
survivors. The appropriate strains were generated
from freshly dissected spores and examined by serial
Figure 2. Sumoylation of Sgs1 occurs in a lesion-dependent manner. (A) Cells were grown to early log phase and treated with either IR or the
indicated concentrations of genotoxic agents for 2h. Lysates were harvested and analyzed by western blot analysis as described in Figure 1. The
eﬃciencies of damage levels were conﬁrmed by Rad53 activation (bleomycin, IR, EMS and HU) or survival rate (H2O2) after treatment (data not
shown). (B) Cells of the indicated genotype were grown to early log phase, serially diluted in 5-fold increments and spotted onto YPD plates
containing the indicated levels of MMS. The plates were photographed after 2 days at 30 C.
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tlc1D and tlc1D sgs1 strains showed a cellular senescence
phenotype on the third restreak (Figure 4B), while the
tlc1D rad51D sgs1D spores senesced at the ﬁrst restreak
and completely lost viability at the second restreak.
These results indicate that the triple mutation prevents
all three (telomerase, Types I and II) pathways for
telomere maintenance and blocked survivor formation.
While the tlc1D rad51D cells senesced at the ﬁrst restreak
and survivors developed at the second restreak, the tlc1D
rad51D sgs1-K621R strain showed cellular senescence
phenotype at both the ﬁrst and second restreaks, and
survivors developed at the third restreak (Figure 4B).
This delayed survivor formation in the tlc1D rad51D back-
ground is consistent with the observation that the
Sgs1-K621R protein is unable to stimulate Type II recom-
bination (Figure 4A). Thus, the sgs1-K621R mutation
reduces telomere–telomere recombination for telomeric
maintenance and subsequently delays survivor formation
in the tlc1D rad51D background.
Sumoylation of Sgs1 is dispensable for other homologous
recombination pathways
Sgs1 acts both early in the homologous recombination
pathway (i.e. during 50-end resection), and late (i.e. disso-
lution of hemi-catenated products) (13,14). To test
whether Sgs1 sumoylation plays a role in homologous
recombination, we examined the phenotype of the
sumoylation-defective alleles in several recombination
assays. To examine direct repeat recombination, we took
advantage of a plasmid (41) containing a duplicated
600-bp internal fragment of LEU2, separated by inter-
vening sequences (Figure 5A). If Sgs1 sumoylation is
required for direct repeat recombination, the sgs1-K621R
mutation would be expected to have phenotype like that
of sgs1D cells. As shown in Figure 5A, both sgs1-K621R
and sgs1-K831R mutants exhibited recombination
Figure 3. Sgs1 K621 sumoylation promotes telomere–telomere recombination. Telomerase deﬁcient (tlc1D) strains carrying the indicated SGS1
alleles were repeatedly diluted and grown to saturation in liquid culture. Following the indicated rounds of growth, cells were harvested and
genomic DNA was isolated. DNA was then digested and Southern blotted with a telomeric probe as described in the ‘Materials and Methods’
section. Data shown here are representative of three or more experiments using independent spore clones. The increased intensity of the smallest
band in panels 2 and 3 is due to Y0–Y0 ampliﬁcation from Type I survivors.
Figure 4. Sgs1 K621 sumoylation promotes Type II telomere recombi-
nation. (A) A growth competition assay was performed on tlc1D and
tlc1D sgs1-K621R strains to test the role of Sgs1 sumoylation in the
absence of telomerase. After the indicated number of rounds of growth,
genomic DNA was obtained and the fraction of cells carrying each
allele was determined by real-time PCR. Plotted on the Y-axis is the
average allele frequency from three independent experiments±SDs.
Signiﬁcant diﬀerences (P<0.001), as determined by the student’s
t-test, are indicated by asterisks. (B) Freshly isolated spores of indicated
strains were repeatedly streaked onto YPD plates and grown for 3
days. Growth from the ﬁrst four streaks are shown.
Nucleic AcidsResearch, 2010, Vol.38,No. 2 493frequencies similar to that of wild-type cells. And consis-
tent with previous reports (46), a hyper-recombination
phenotype was observed in sgs1D cells (Figure 5A).
Based on these results, sumoylation of Sgs1 does not par-
ticipate in the regulation of homologous recombination by
direct repeats.
Rad52 is a key player in most homologous recombina-
tion processes, including gene conversion, reciprocal
exchange, single-strand annealing, telomere recombina-
tion and break-induced replication (47). Rad52 is also
sumoylated, and mutation of its sumoylation sites has a
minor eﬀect on homologous recombination. However,
inter-chromosomal recombination between heteroallelic
markers is regulated by Rad52 sumoylation (48,49).
We therefore tested whether Sgs1 sumoylation aﬀected
recombination between the his1-1 and his1-7 heteroalleles.
However, as shown in Figures 5B and C, sgs1-K621R cells
showed recombination frequencies that were similar to
those of wild-type cells, including events induced by
MMS. In contrast, the sgs1 null mutant showed severe
defects in these assays (50).
It has been reported that the role of Sgs1 in DNA rep-
lication can be uncoupled from its role in homologous
recombinational repair by mutating certain residues in
the acidic region of Sgs1 (Figure 1D) (51). Since the
K621 residue localizes to this region, we tested whether
its sumoylation is required for Sgs1 to promote DNA rep-
lication. Deletion of SGS1 suppresses the mitotic cell cycle
delay of a top3 mutant (42), and this implies that Sgs1
generates an intermediate that is normally resolved by
Top3 in the S phase. However, as shown in Figure 5D,
the slow growth of top3D cells was not suppressed by
Figure 5. Recombination phenotypes of SUMO-deﬁcient Sgs1. (A) Recombination frequency of direct repeat was determined by the pRS314-Lu
system (62). Recombination frequencies were calculated using the median method of Lea and Couison (63). (B) Schematic representation of inter-
chromosomal recombination between his1-1 and his1-7 heteroalleles in diploid cells. Data shown here are the averages of four independent
experiments (n=12). Recombination-deﬁcient rad52 mutant was served as a negative control. (C) MMS-induced inter-chromsomal recombination
frequency was evaluated using the his1-1/his1-7 heteroallelic system described in (B). Data here are the fold enrichments upon 0.01% MMS
treatment. (D) Slow growth phenotype was examined in strains combined with the top3 deletion. Exponentially growing cells were 5-fold serially
diluted and spotted onto YPD plates.
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does not inﬂuence the repair of DNA replication
intermediates. Taken together, these assays demonstrate
that sumoylation of Sgs1 is speciﬁcally required for
telomere–telomere recombination, but is dispensable for
other types of homologous recombination and replicative
repair.
Sumoylation of Sgs1 is not involved in rDNA
recombination
Since Sgs1 sumoylation is required for Type II telomere–
telomere recombination but not other types of homolo-
gous recombination, we speculated that this might be
due to its specialized telomeric heterochromatin. For
example, sumoylation of Sgs1 might be required for the
helicase to gain access to telomeric DNA that is main-
tained in the form of heterochromatin. To test the gener-
ality of this idea, we assayed recombination at the rDNA
array because of its heterochromatic character (52,53). A
URA3 marker was inserted in the rDNA locus of an sgs1D
strain, and wild-type or mutant SGS1 plasmids were
transformed into this strain. The frequency of rDNA
recombination was determined by excision of the URA3
marker. As shown in Figure 6, no diﬀerence in the fre-
quency of rDNA recombination was observed between the
wild-type and sgs1-K621R strains. Based on these ﬁndings,
we conclude that Sgs1 sumoylation does not play a general
role in the regulation of homologous recombination,
but speciﬁcally promotes Type II telomere–telomere
recombination.
DISCUSSION
Several RecQ DNA helicases have been shown to be
sumoylated (17–19). However, the exact function of this
modiﬁcation in homologous recombination is not well
understood. Here, we have show that Sgs1 sumoylation
is induced in response to DSBs, and that K621 is the
major site of Sgs1 sumoylation. We were surprised to
ﬁnd that sumoylation is dispensable for most biological
functions of Sgs1, including homologous recombination
and promoting top3D slow growth. However, sumoylation
of K621 is essential for promoting Type II telomere–
telomere recombination. While it is not clear whether
sumoylation is required for the human RecQ helicases to
carry out homologous recombination, our data are con-
sistent with the very recent ﬁndings that Rqh1
sumoylation is crucial for determining the pathway for
repair of dysfunctional telomeres in S. pombe (16).
In budding yeast, Rad52, Smc5/6 and Sgs1 are all
necessary for homologous recombination, and are all
sumoylated. It has been suggested that concurrent
sumoylation of several homologous recombination-
related proteins may be required to orchestrate the eﬃ-
cient execution of DNA damage-induced homologous
recombination (48). In that respect, it is important to
note that many studies have found a link between
speciﬁc subnuclear localization and protein modiﬁcation
by SUMO (18,38,54). Thus, upon DNA damage, multiple
components of the homologous recombination machinery
may necessarily co-localize at sites of sumoylation where
some of them undergo SUMO modiﬁcation to speciﬁcally
alter their enzymatic activity. For example, Rad52
sumoylation, which is triggered by DSBs in an MRX-
dependent manner, modiﬁes Rad52 activity in inter-
chromosomal recombination between heteroallelic
markers (48). This mechanism appears to be conserved
in human cells, where RecQ helicases and the recombina-
tion proteins RAD51, RPA and PML co-localize to PML
bodies upon IR treatment (55), and sumoylation is
required for the formation of the nuclear foci of these
repair proteins (54,56). In our hands, however, Sgs1
sumoylation was not required for most of its roles in
homologous recombination. One explanation for this
result, although unattractive, is that Sgs1 sumoylation
occurs non-speciﬁcally because of its close association
with other recombination factors and an indiscriminate
sumoylation machinery. However, it is more likely that
the small fraction of Sgs1 molecules that is modiﬁed
by SUMO in response to DSBs represents a pool
of proteins whose novel functions are redundant with
other recombination proteins or pathways. For example,
in the absence of sumoylation, Sgs1-K621R may be
activated for recombinational repair by back-up
pathways or other posttranslational modiﬁcations. These
modiﬁcations may be transient or constitute a pool size
that is beyond our detection limit. If this second modiﬁ-
cation is essential for activating Sgs1-K621R, then its loss
should result in synthetic interactions with sgs1-K621R.
Thus, a screen for synthetic interactors with sgs1-K621R
would be one approach to identify these other proteins
or pathways.
If sumoylation does not contribute to the major roles
of Sgs1 in homologous recombination, how does
Sgs1 sumoylation speciﬁcally promote telomere–telomere
recombination? A plausible explanation is that sumoy-
lation is required to localize Sgs1 to telomeres for
telomere–telomere recombination. As a mechanism for
redistribution, sumoylation may provide better accessibil-
ity for Sgs1 to act on its telomeric substrates. In support of
this idea, it has been shown that abolition of the Pli1
Figure 6. SUMO-defective Sgs1 does not aﬀect rDNA recombination.
An sgs1 strain with the URA3 insertion in the rDNA locus was
transformed with a CEN-based plasmid carrying wild-type SGS1 or
sgs1 mutants. The rDNA recombination rate of each strain was
calculated as described in Figure 5A. Data here are the averages of
three independent experiments.
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silencing and length regulation in S. pombe (57). The
ability of global sumoylation levels to inﬂuence telomeres
in this way argues that sumoylation is an important player
in telomere maintenance. Similarly, the SMC5/6 complex
facilitates telomere–telomere recombination and elonga-
tion in ALT cells by promoting ALT-associated PML
body formation via the sumoylation of multiple telomere
binding proteins (58). And intra-nuclear traﬃcking
of the BLM helicase to DNA damage-induced foci is
also regulated by SUMO modiﬁcation (18). All of these
ﬁndings point to the possibility that sumoylation mediates
the localization of multiple recombination proteins,
including RecQ helicases, to telomeres to execute
telomere–telomere recombination.
Sgs1 and its ortholog Rqh1 mediate the restart of stalled
replication forks in both S. cerevisiae (59) and S. pombe
(60). If telomeric recombination is initiated by the repair
of stalled or collapsed replication forks, then it would be
expected that a deﬁciency in Sgs1 would impact the fre-
quency, and perhaps the mechanism, of telomere–telomere
recombination. In addition, telomeric heterochromatin
may present unique challenges to replication forks or
their repair. For example, the telomere-speciﬁc phenotype
observed here might be due to the fact that telomeric
chromatin is actively repressed by Rap1 and other
factors (61). Our data would seem to argue against this
possibility since rDNA recombination was not modulated
by Sgs1 sumoylation. However, the requirements for
rDNA heterochromatin are not identical to those at the
telomere (52,53). Thus, it remains a possibility that the
strand transfer reactions that occur during telomere–
telomere recombination must overcome obstacles not
found in euchromatin or the rDNA. Our data suggests
that Sgs1 sumoylation is involved in dealing with these
challenges, perhaps by ensuring that the Sgs1 complex is
targeted to these recombination sites.
Amino acid sequence alignment of the Sgs1, Rqh1 and
BLM orthologs reveals a RecQ DNA helicase domain that
is highly conserved, and an N-terminal domain of about
650 amino acids that shows little if any sequence conserva-
tion (Supplementary Figure S3). It is interesting to note
that each of the sumoylation sites that have been identiﬁed
in these three proteins are located in diﬀerent domains
of the protein (Supplementary Figure S3 and Figure 1D).
This indicates that while sumoylation may be a conserved
mechanism for modifying these RecQ helicases, there is no
requirement that SUMO be conjugated to the same residue
or even the same domain of the protein. Further studies
will be needed to determine how sumoylation of the
BLM orthologs aﬀects each of their enzymatic activities
and nuclear distribution. It is expected that such
studies will shed light on whether the mechanism of
SUMO modiﬁcation is functionally conserved between
these organisms.
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